Athens Water Supply and Sewerage Company S.A (EYDAP)
Athens Exchange · Greece · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 13.80 |
|---|---|
| 52-week range | 6.40 – 14.08 |
| Return, 1 month / 3 months | +10.6% / +23.9% |
| Return, 1 year / 3 years | +106.0% / +155.3% |
| Trend | Uptrend |
| RSI (14) | 69 |
| Volatility (1 year) | 33.9% |
| Worst drawdown (1 year) | -13.8% |
| Average daily value traded | 1.17M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Athens Water Supply and Sewerage Company supplies drinking water and provides sewerage and wastewater treatment services to households, businesses and public bodies in and around Athens, Greece. The company draws, treats and distributes water through its network and collects and treats wastewater before discharge. It is based in Athens and operates as a regulated utility serving the Greek capital region.
Athens Water Supply and Sewerage Company S.A trades under the code EYDAP on the Athens Exchange in Greece, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Athens Water Supply and Sewerage Company S.A (EYDAP) trades on the Athens Exchange in Greece. It last closed at EUR 13.80 on 22 October 2026.
Its price-based Market X-Ray is 84 out of 100 (a strong price profile), ranking 4 of 143 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 106.0% and over the last three months it rose 23.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Athens Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 94 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 34.0% | ||
| From 52-week high | -1.1% | ||
| Momentum | 93 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 23.9% | ||
| 6-month return | 46.2% | ||
| 12-month return, skipping the last month | 86.3% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.8% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 1.17M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.8% |
|---|---|
| 1 month | +10.6% |
| 3 months | +23.9% |
| 6 months | +46.2% |
| 1 year | +106.0% |
| 3 years | +155.3% |
| 5 years | +92.8% |
Signals
| 50-day / 200-day average | 12.41 / 10.30 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.46 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Sep 2022 | EUR 0.2800 |
| 13 Sep 2021 | EUR 0.2300 |
| 30 Jun 2021 | EUR 0.2400 |
| 30 Jun 2020 | EUR 0.3800 |
| 28 Jun 2019 | EUR 0.2700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Athens Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.